Insider Transactions Reported by 18 Insiders of Skye Bioscience, Inc.

Symbol
SKYE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director $34,663,397 -$800,549 -2.3% 06 Feb 2026
5AM Partners VII, LLC 10%+ Owner $34,663,397 -$800,549 -2.3% 21 Aug 2025
Versant Ventures III, LLC 10%+ Owner $9,386,012 18 Aug 2023
Emerald Health Sciences Inc. 10%+ Owner $3,167,928 10 Nov 2022
Kaitlyn Arsenault Chief Financial Officer $835,935 06 Feb 2026
Christopher Twitty Chief Scientific Officer $147,251 06 Feb 2026
James L. Heppell Director 14 Sep 2021
Deborah H. Charych Director 06 Feb 2026
MARGARET DALESANDRO Director 29 Feb 2024
PRAVEEN TYLE Director 29 Feb 2024
Paul A. Grayson Director 06 Feb 2026
Keith Wayne Ward Director 29 Feb 2024
PUNIT DHILLON Chief Executive Officer, Director 06 Feb 2026
Tuan Tu Diep Chief Development Officer 06 Feb 2026
Sukhwinder Singh Rai Director 05 Jan 2023
Annalisa Jenkins Director 06 Feb 2026
Karen L. Smith Director 06 Feb 2026
Puneet S. Arora Chief Medical Officer 06 Feb 2026

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.